fashion -WSS

fashion

author：entertainment 2025-10-01 00:00:10 - browse：48

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： What Kate Middleton's cancer revelation might teach the world

focus

WSS

This gene therapy has record $4.25 million price. It's saved children.

Erich Jarvis studies song birds to learn about human stuttering

Primary care doctor shortage won't be solved by free med school tuition

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

As billionaires fund anti

Novel spinal cord stimulator treats paralysis without surgery

explore

fashion

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

AltruBio raises $225 million to develop ulcerative colitis drug

Hepatitis C has a cure — but many Americans still lack access to it

Has Bernie Sanders reached the limit of his pharma bullying effort?

Apple is now the first public company to be valued at $3 trillion

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AI for drug discovery: Experts on separating hype from reality

Jerome Adams on the need for new antivirals for Covid

PBM executives asked to testify by House panel

hotspot

Deliver public health messages at the right time

Empower primary care with adequate payments and technology

Can gargling with Listerine treat gonorrhea of the mouth?

PBM executives asked to testify by House panel

Chinese researcher claims birth of first gene

Adam's Take: Intra

focus

focus

entertainment

Wikipedia